查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439898

血小板聚集設備 - 全球市場回顧、競爭格局、市場預測(2030)

Platelet Aggregation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球血小板聚集設備市場規模將於2023年達到3.6554億美元，2030年將達到5.7325億美元，預計2024-2030年期間複合年增長率為7.85%。 由於心血管疾病、血液疾病和其他針對性疾病盛行率上升，以及全球老年人口負擔迅速增加等多種因素，該市場正呈現正成長。 此外，血小板聚集儀技術的進步，例如血小板的精確自動化測試，將在未來幾年增加對該設備的需求。 此外，醫療產業產學合作和臨床研究的增加也將有助於血小板聚集設備市場的成長。 此外，全球監管機構批准和上市的增加將進一步促進血小板聚集設備市場的整體成長。 因此，預計在 2024-2030 年預測期內，血小板聚集設備市場將以顯著的複合年增長率成長。

血小板聚集裝置市場動態

血小板聚集設備市場的主要驅動因素之一是出血和血液疾病的增加。

例如，國家罕見疾病組織 (NORD) 在最近的一項研究中指出，美國成年人中免疫性血小板減少症 (ITP) 的盛行率估計為每年每 10 萬人中 3.3 例。 此外，據報導 ITP 盛行率為每 10 萬人 9.5 人。 此外，馬里蘭州衛生保健委員會的一項調查(2023)發現，2022年美國1至5歲兒童ITP盛行率為每10萬中9.5例，6至10歲兒童每10萬中7.3例，據估計，每10 萬名11 歲至14 歲的人中就有4.1 人患有此病。

免疫性血小板減少症(ITP)是血小板疾病的一種，可以藉助血小板聚集裝置進行診斷。 因此，ITP數量的增加將增加診斷測試，最終增加對血小板聚集設備市場的需求。

此外，其他出血和血小板疾病的日益普及將推動血小板聚集設備市場的發展。 例如，伯納德蘇利爾症候群是一種罕見的出血性疾病，影響男性和女性的人數相同。 NORD 最近的一項研究估計，每 100 萬人中就有 1 人患有 Bernard Soulier 綜合徵。 2022 年，全球報告了 200 多例病例。 可以使用血小板聚集裝置來檢測此類症候群。

此外，對血小板聚集系統的需求主要源於瞭解血小板與血管表面相互作用機制的研究，以及瞭解抗血小板藥物新靶點的抗血栓因子的評估和篩選。在學術機構和製藥公司。 因此，不斷增加的研發活動和臨床試驗將推動未來幾年市場對該設備的需求。

因此，在 2024-2030 年預測期內，上述因素將共同推動整個血小板聚集設備市場的發展。

然而，產品供應量下降、缺乏訓練有素且技術熟練的專業人員以及程序限制可能會阻礙全球血小板聚集設備市場的成長。

COVID-19 大流行對血小板聚集設備市場產生了負面影響。 疫情的爆發導致門診取消，並暫停了針對癌症、糖尿病和心血管疾病等慢性疾病的非急診醫院和外科手術。 此外，由於優先考慮 COVID-19 檢測，許多疾病的診斷檢測有所減少。 此外，由於嚴格的封鎖規定，該設備的生產已停止。 然而，隨著封鎖規定的放鬆和經濟狀況的正常化，COVID-19 疫苗的開發將創造一個經濟復甦的過程，增加對常規醫療服務、診斷測試和手術程序的需求，以治療和管理各種疾病。開始恢復手術進程，導致血小板聚集設備市場需求增加，使血小板聚集設備市場的設備需求重回正軌。

本報告研究和分析了全球血小板聚集設備市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章血小板聚集設備市場報告簡介

第2章血小板聚集設備市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章血小板聚集儀市場主要因素分析

  • 推動血小板聚集設備市場的因素
    • 心血管疾病、血液疾病和其他目標疾病的盛行率不斷上升
    • 人口老化負擔激增
    • 血小板聚集儀技術的進步
    • 加強產學合作與臨床研究
  • 血小板聚集設備市場的抑制因素與挑戰
    • 產品供應量減少
    • 缺乏訓練有素、技術熟練的專業人員
    • 治療限制
  • 血小板聚集裝置的市場機會
    • 診斷實驗室採用自動化系統並提高市場偏好
    • 結合床邊護理與小型血小板聚集儀

第5章血小板聚集設備市場波特五力分析

第6章COVID-19對血小板聚集設備市場的影響分析

第7章血小板聚集裝置市場佈局

  • 依產品類型
    • 系統
    • 試劑
    • 消耗品和配件
  • 依用途
    • 臨床應用
    • 研究用途
  • 按最終用戶
    • 醫院
    • 診斷實驗室
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章血小板聚集裝置市場：全球公司佔有率分析 - 3 至 5 家主要公司

第9章血小板聚集裝置市場公司及產品概況

  • F. Hoffmann-La Roche Ltd
  • Werfen
  • Drucker Diagnostics
  • Haemonetics Corporation
  • Sienco, Inc.
  • BIO/DATA CORPORATION
  • AggreDYNE
  • Siemens Healthcare Private Limited
  • Chrono-log Corporation
  • Grifols, S.A.
  • Helena Laboratories Corporation.
  • SENTINEL.
  • Sysmex Corporation
  • Matis Medical Inc.
  • Behnk Elektronik GmbH & Co.

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0575

Platelet Aggregation Devices Market By Product Type (Systems, Reagents, And Consumables & Accessories), By Application (Clinical Applications And Research Applications), By End-User (Hospitals, Diagnostic Laboratories, And Others) and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing number of target disorders and increasing number of research and clinical studies worldwide

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030. The platelet aggregation devices market is witnessing positive growth owing to various factors such as the rising prevalence of cardiovascular, hematological, and other target disorders and surging burden of geriatric population across the globe. Further, technological advancements in platelet aggregometers, for instance accurate and automatic testing of platelets and other advancements will increase the demand of the device in the forthcoming years. Additionally, the rise in the number of industry-academia collaborations and clinical studies in the healthcare industry will also contribute in the growth of platelet aggregation devices market. Also, the increasing regulatory approvals and launches across the globe will further increase the overall growth of the platelet aggregation devices market. Therefore, the market for platelet aggregation devices market is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.

Platelet Aggregation Devices Market Dynamics:

One of the main driver for the platelet aggregation devices market is the increasing figures of bleeding and haematological disorders.

For instance, the National Organization for Rare Disorders (NORD) stated in a latest study the incidence of adult Immune thrombocytopenia (ITP) in the United States was roughly estimated to be 3.3 per 100,000/year. Also, the prevalence od ITP was reported to be 9.5 per 100,000. Further, in a study done by the Maryland Health Care Commission (2023), the prevalence of ITP was estimated to be 9.5 per 100,000 children ages 1-5, 7.3 per 100,000 in children ages 6-10, and 4.1 per 100,000 in children of ages 11-14, in 2022, in the United States.

Immune thrombocytopenia (ITP) is a type of platelet disorder, whose diagnosis can be done with the help of platelet aggregation devices market. Thus, the increasing figures of ITP will increase the number of diagnosis test, ultimately rising the demand of the platelet aggregation devices market.

Further, increasing incidence of other bleeding and platelet disorder will drive the market of platelet aggregation devices market. For instance, Bernard-Soulier syndrome is a rare bleeding disorder that affects males and females in equal numbers. Recent study done by NORD suggests that Bernard Soulier syndrome affects 1 in a million people. More than 200 cases have been reported in 2022, worldwide. The detection of such syndromes can be done using platelet aggregation devices market.

Additionally, the demand for platelet aggregation systems is increasing in academic and pharmaceutical companies due to the increase in research studies, mainly to know the mechanisms involved in the interaction of platelets with vascular surfaces and evaluation and screening anti-thrombotic factors to know new targets for antiplatelet drugs. Thus, the increasing research & developmental activities and clinical trials will propel the demand of the device in the market in upcoming years.

Therefore, the factors stated above collectively will drive the overall market of platelet aggregation devices market during the forecast period from 2024-2030.

However, reduced product availability, lack of trained and skilled professionals, procedural limitations, and others, can hinder the global platelet aggregation devices market growth.

The COVID-19 pandemic has negatively impacted the market for platelet aggregation devices market. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, and others. Moreover, the number of diagnostic tests many disorders were reduced as the priority was given to the covid-19 testing. Further, due to imposition of strict lockdown rules the manufacturing of the devices was ceased. However, vaccine development of COVID-19 has produced the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services, diagnostic tests, and surgical procedures for the treatment and management of various diseases ultimately increasing the demand of platelet aggregation devices market, thereby bringing the demand for device on track in the platelet aggregation devices market.

Platelet Aggregation Devices Market Segment Analysis:

Platelet aggregation devices market by Product Type (Systems, Reagents, and Consumables & Accessories), Application (Clinical Applications and Research Applications), End-User (Hospitals, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the platelet aggregation devices market, the systems market is expected to have a significant revenue share in the year 2023. This was primarily owing to the application of the segment. Moreover, the advantages such as accuracy, portability, and others offered by the systems along with the increasing product launches in the market will spur the demand of the segment in the upcoming years.

The systems are specifically designed to support diagnoses of hemostasis disorders including von Willebrand Disease (vWD), Glanzmann's disease, HIT, Bernard Soulier Syndrome, Sticky Platelet Syndrome, and others. The platelet aggregation systems can also be used to precisely monitor the use of anti-platelet drugs during clinical trials or patient therapy. Moreover, the system measures the rate and extent of aggregation, agglutination, activation and inhibition reactions. Thus, the increasing prevalence of any of the above disorder can propel the demand of systems segment in the forecast period.

Further, the automated platelet aggregometry systems offer various advantages such as accuracy, reduced platelet-rich plasma volume and time, simultaneous assay and test conduction, and other advantages will increase its demand in the market.

The rising regulatory activities and launches will in turn propel the demand of the systems in the market, thereby propelling the overall growth of platelet aggregation devices market. For instance, in March 2020, Hart Bio launched ADP MEA and TRAP-6 MEA, designed to monitor and test the platelet aggregation function of patients. Both ADP MEA and TRAP-6 MEA are designed to monitor and test the platelet aggregation function of patients.

Thus, the above-mentioned factors will in turn drive the systems segment market in platelet aggregation devices market, thereby propelling the overall market growth of platelet aggregation devices market in the forecast period from 2022 - 2028.

North America is expected to dominate the overall Platelet Aggregation Devices Market:

Among all the regions, North America is expected to dominate the global platelet aggregation devices market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as the increasing number of target disorders, increasing geriatric population, technological advancements in platelet aggregometer, rising awareness among healthcare professionals regarding the benefits offered by platelet aggregation testing in disease diagnosis, and others will increase the demand for platelet aggregation devices market in North America, leading to a rise in the overall platelet aggregation devices market growth.

For instance, as per a report provided by Centers for Disease Control (CDC) in 2022, every 40 seconds, an American may have a heart attack. Platelet function tests using platelet aggregation devices market are used to monitor the antiplatelet drugs as a means to predict in cardiovascular disease. Thus, increasing prevalence of cardiovascular disorders in the North America will increase the number of platelet function test, thus leading to a higher demand for platelet aggregation devices market, which will drive the market in the North America.

Further, the increasing prevalence of bleeding and hematological disorders will shoot the demand of the device. According to the World Federation of Hemophilia 2022 report, there were about 14,816 patients with hemophilia including (Hemophilia A -11,790 and Hemophilia B-3,026) in the United States in 2020 and 3,924 patients with hemophilia in Canada in 2020 including (Hemophilia A -3,223 and Hemophilia B-701). Therefore, platelet aggregation testing is found to be very beneficial in disease diagnosis.

Additionally, factors such as the rising number of surgical procedures in this country, a large number of the population undergoing cardiovascular surgeries, increasing prevalence of orthopedic, bleeding, and urological disorders are creating high growth opportunities for the market players in the North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the platelet aggregation devices market.

Platelet Aggregation Devices Market Key Players:

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

Recent Developmental Activities in the Platelet Aggregation Devices Market:

In July 2022, Sysmex Corporation, a leading name in the global platelet aggregation devices marketplace, announced the launch of new automated blood coagulation analyzers. CN-3500 and CN-6500 are capable of measuring platelet aggregation parameters and blood coagulation in hemostasis and thrombosis fields.

In December 2020, Basking Biosciences Inc., a private biopharmaceutical organization, announced that it had successfully raised US$ 5.4 million in a seed financing round. The company was working on exploring the role of vWF, a redundant mediator of platelet adhesion and aggregation, to develop a reversible thrombolytic therapy for acute ischemic stroke. Rising outbreaks of dengue & malaria and growing incidence of blood cancer are also expected to drive platelet aggregation system demand in this region.

In April 2019, Aggredyne Inc. received the US FDA approval for AggreGuide A-100 ADP assay testing cartridge, an in vitro diagnostic device used for measuring various antiplatelet medications that target the platelet P2Y12 receptor.

Key Takeaways from the Platelet Aggregation Devices Market Report Study

  • Market size analysis for current platelet aggregation devices market (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the platelet aggregation devices market
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the global platelet aggregation devices market
  • Various opportunities are available for the other competitor in the platelet aggregation devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current platelet aggregation devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for platelet aggregation devices market growth in the coming future?

Target Audience who can be benefited from this Platelet Aggregation Devices Market Report Study

  • Platelet aggregation devices market providers
  • Research organizations and consulting companies
  • Platelet aggregation devices market -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in platelet aggregation devices market
  • Various end-users who want to know more about the platelet aggregation devices market and the latest technological developments in the platelet aggregation devices market

Frequently Asked Questions for Platelet Aggregation Devices Market:

1. What are platelet aggregation devices market?

Platelet aggregation is the procedure in which the platelets are clomped together in the blood which leads to the formation of a thrombus or clot. The devices involved in the aggregation of platelets are termed as platelet aggregation devices market. The aggrometers, one of the medical device used in platelet aggregation, works against the clotting, to further stop the clot formation. This process is used for the diagnosis and identification of the defects in platelet functions.

2. What is the market for Platelet aggregation devices market?

The global platelet aggregation devices market was valued at USD 365.54 million in 2023, growing at a CAGR of 7.85% during the forecast period from 2024 to 2030 to reach USD 573.25 million by 2030.

3. What are the drivers for the platelet aggregation devices market?

The platelet aggregation devices market is observing an affirmative market growth owing to the factors such as rising prevalence of cardiovascular, haematological, and other target disorders, surging burden of geriatric population, technological advancements in platelet aggregometers, rise in the number of industry-academia collaborations and clinical studies, and the upsurge in the regulatory approvals for platelet aggregation devices market.

4. Who are the key players operating in the platelet aggregation devices market?

Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL., Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.

5. Which region has the highest share in platelet aggregation devices market?

North America is expected to dominate the global platelet aggregation devices market. Factors contributing to the growth are the rising number of cardiovascular surgeries, rising number of orthopaedic, urological, bleeding, and disorders, escalating burden of geriatric patients, and others which are contributing to the growth of the platelet aggregation devices market in the North America region.

Table of Contents

1.Platelet aggregation devices market Report Introduction

2.Platelet aggregation devices market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The US
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Platelet aggregation devices market Key Factors Analysis

  • 4.1. Platelet aggregation devices market Drivers
    • 4.1.1. Rising prevalence of cardiovascular, hematological, and other target disorders
    • 4.1.2. Surging burden of geriatric population
    • 4.1.3. Technological advancements in platelet aggregometers
    • 4.1.4. Rise in the number of industry-academia collaborations and clinical studies
  • 4.2. Platelet aggregation devices market Restraints And Challenges
    • 4.2.1. Reduced product availability
    • 4.2.2. Lack of trained and skilled professionals
    • 4.2.3. Procedural limitations
  • 4.3. Platelet aggregation devices market Opportunities
    • 4.3.1. Growing adoption and market preference for automated systems among diagnostic laboratories
    • 4.3.2. Incorporation of point-of-care and miniaturized platelet aggregometers

5. Platelet aggregation devices market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Platelet aggregation devices market

7. Platelet aggregation devices market Layout

  • 7.1. By Product Type
    • 7.1.1. Systems
    • 7.1.2. Reagents
    • 7.1.3. Consumables and Accessories
  • 7.2. By Application
    • 7.2.1. Clinical Applications
    • 7.2.2. Research Applications
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.6. Russia Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.2.7. Rest of Europe Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1. China Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.3. India Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia Pacific Platelet aggregation devices market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Platelet aggregation devices market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Platelet aggregation devices market Size in USD Million (2021-2030)

8. Platelet aggregation devices market Global Company Share Analysis - Key 3-5 Companies

9. Platelet aggregation devices market Company and Product Profiles

  • 9.1. F. Hoffmann-La Roche Ltd
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Werfen
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Drucker Diagnostics
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Haemonetics Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Sienco, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. BIO/DATA CORPORATION
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. AggreDYNE
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Siemens Healthcare Private Limited
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Chrono-log Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Grifols, S.A.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Helena Laboratories Corporation.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. SENTINEL.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Sysmex Corporation
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Matis Medical Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Behnk Elektronik GmbH & Co.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Platelet aggregation devices market in Global (2021-2030)
  • Table 4: Platelet aggregation devices market in Global by Product Type (2021-2030)
  • Table 5: Platelet aggregation devices market in Global by Application (2021-2030)
  • Table 6: Platelet aggregation devices market in Global by End-User (2021-2030)
  • Table 7: Platelet aggregation devices market in Global by Geography (2021-2030)
  • Table 8: Platelet aggregation devices market in North America (2021-2030)
  • Table 9: Platelet aggregation devices market in North America by Country (2021-2030)
  • Table 10: Platelet aggregation devices market in the US (2021-2030)
  • Table 11: Platelet aggregation devices market in Canada (2021-2030)
  • Table 12: Platelet aggregation devices market in Mexico (2021-2030)
  • Table 13: Platelet aggregation devices market in Europe (2021-2030)
  • Table 14: Platelet aggregation devices market in Europe by Country (2021-2030)
  • Table 15: Platelet aggregation devices market in France (2021-2030)
  • Table 16: Platelet aggregation devices market in Germany (2021-2030)
  • Table 17: Platelet aggregation devices market in the United Kingdom (2021-2030)
  • Table 18: Platelet aggregation devices market in Italy (2021-2030)
  • Table 19: Platelet aggregation devices market in Spain (2021-2030)
  • Table 20: Platelet aggregation devices market in Russia (2021-2030)
  • Table 21: Platelet aggregation devices market in Rest of Europe (2021-2030)
  • Table 22: Platelet aggregation devices market in APAC (2021-2030)
  • Table 23: Platelet aggregation devices market in APAC by Country (2021-2030)
  • Table 24: Platelet aggregation devices market in China (2021-2030)
  • Table 25: Platelet aggregation devices market in Japan (2021-2030)
  • Table 26: Platelet aggregation devices market in India (2021-2030)
  • Table 27: Platelet aggregation devices market in Australia (2021-2030)
  • Table 28: Platelet aggregation devices market in South Korea (2021-2030)
  • Table 29: Platelet aggregation devices market in Rest of APAC (2021-2030)
  • Table 30: Platelet aggregation devices market in Rest of World (2021-2030)
  • Table 31: Platelet aggregation devices market in RoW by Region (2021-2030)
  • Table 32: Platelet aggregation devices market in Middle East (2021-2030)
  • Table 33: Platelet aggregation devices market in Africa (2021-2030)
  • Table 34: Platelet aggregation devices market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Platelet aggregation devices market in Global (2021-2030)
  • Figure 4: Platelet aggregation devices market in Global by Product Type (2021-2030)
  • Figure 5: Platelet aggregation devices market in Global by Application (2021-2030)
  • Figure 6: Platelet aggregation devices market in Global by End-User (2021-2030)
  • Figure 7: Platelet aggregation devices market in Global by Geography (2021-2030)
  • Figure 8: Platelet aggregation devices market in North America (2021-2030)
  • Figure 9: Platelet aggregation devices market in North America by Country (2021-2030)
  • Figure 10: Platelet aggregation devices market in the US (2021-2030)
  • Figure 11: Platelet aggregation devices market in Canada (2021-2030)
  • Figure 12: Platelet aggregation devices market in Mexico (2021-2030)
  • Figure 13: Platelet aggregation devices market in Europe (2021-2030)
  • Figure 14: Platelet aggregation devices market in Europe by Country (2021-2030)
  • Figure 15: Platelet aggregation devices market in France (2021-2030)
  • Figure 16: Platelet aggregation devices market in Germany (2021-2030)
  • Figure 17: Platelet aggregation devices market in the United Kingdom (2021-2030)
  • Figure 18: Platelet aggregation devices market in Italy (2021-2030)
  • Figure 19: Platelet aggregation devices market in Spain (2021-2030)
  • Figure 20: Platelet aggregation devices market in Russia (2021-2030)
  • Figure 21: Platelet aggregation devices market in Rest of Europe (2021-2030)
  • Figure 22: Platelet aggregation devices market in APAC (2021-2030)
  • Figure 23: Platelet aggregation devices market in APAC by Country (2021-2030)
  • Figure 24: Platelet aggregation devices market in China (2021-2030)
  • Figure 25: Platelet aggregation devices market in Japan (2021-2030)
  • Figure 26: Platelet aggregation devices market in India (2021-2030)
  • Figure 27: Platelet aggregation devices market in Australia (2021-2030)
  • Figure 28: Platelet aggregation devices market in South Korea (2021-2030)
  • Figure 29: Platelet aggregation devices market in Rest of APAC (2021-2030)
  • Figure 30: Platelet aggregation devices market in Rest of World (2021-2030)
  • Figure 31: Platelet aggregation devices market in RoW by Region (2021-2030)
  • Figure 32: Platelet aggregation devices market in Middle East (2021-2030)
  • Figure 33: Platelet aggregation devices market in Africa (2021-2030)
  • Figure 34: Platelet aggregation devices market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis